Taking a shot on BMY
 
   
     
   
 
FEBRUARY 4, 2025
   
 
 
 
 

Hey y’all,

I don’t think I’ve shared this before, but I lead a small weekly Bible study at our office every Tuesday morning.

This morning, after we finished a discussion about Sarah’s role in the Old Testament and the birth of Isaac in Genesis, we wrapped up and got ready to leave…

And the other folks in the small group started talking about their Hard Rock Parlays ahead of the Super Bowl.

Not sure if it’s a sign of a successful small group that the members immediately discuss gambling right afterward 🤣

But this week, instead of betting on the Super Bowl, I’m going to take a slightly more informed gamble on BMY earnings (oh, who am I kidding? I’ll probably do both…) 

And I feel it’s “informed” because I’m following Institutional Order Flow genius Lance Ippolito into this position.

On Thursday, Bristol Myers Squibb (BMY), the Biopharmaceutical company behind Eliquis and other wonderdrugs, will report earnings.

According to Lance, there is $440k of institutional call orders behind this stock heading into the earnings report, meaning that somebody with a lot of information is placing a high-confidence bet on a move higher.

 

Lance is one of the best directional traders I’ve ever seen, and it’s all because he’s able to track where the big money is moving ahead of time and “shadow” their best moves.

And this is one of his Shadow Trades, buying the Feb. 21, 2025, $60 calls for around $1.30 or so.

I bet BIG here, going in on one whole contract! I know, risky business! 

But my account is still pretty small so I’m trying to be smart — never risk more than you can afford to lose! 

So there’s the skinny… I’ll keep you updated on how things go as we get past earnings! 

Talk to you soon.

To your prosperity,

Stephen Ground

ProsperityPub Editor-in-Chief

P.S.: To learn about the strategy Lance uses to “shadow” the biggest money moves on Wall Street, tap here